Periodontal disease in HIV/AIDS

Periodontology 2000

Volumn 60, Issue 1, 2012, Pages 78-97

  Ryder, Mark I ^a   Nittayananta, Wipawee ^a   Coogan, Maeve ^a   Greenspan, Deborah ^a   Greenspan, John S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; ARTICLE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE COURSE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERIODONTAL DISEASE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DISEASE PROGRESSION; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; PERIODONTAL DISEASES;

EID: 84865358480     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/j.1600-0757.2012.00445.x     Document Type: Article

References (187)

1. Aas JA, Barbuto SM, Alpagot T, Olsen I, Dewhirst FE, Paster BJ. Subgingival plaque microbiota in HIV positive patients. J Clin Periodontol 2007: 34: 189-195.
2. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010: 329: 1168-1174.
3. Aichelmann-Reidy ME, Wrigley DL, Gunsolley JC. HIV infection and bone loss due to periodontal disease. J Periodontol 2010: 81: 877-884.
4. Alpagot T, Font K, Lee A. Longitudinal evaluation of GCF IFN-gamma levels and periodontal status in HIV+ patients. J Clin Periodontol 2003: 30: 944-948.
5. Alpagot T, Konopka K, Bhattacharyya M, Gebremedhin S, Duzgunes N. The association between gingival crevicular fluid TGF-beta1 levels and periodontal status in HIV-1(+) patients. J Periodontol 2008: 79: 123-130.
6. Alpagot T, Remien J, Bhattacharyya M, Konopka K, Lundergan W, Duzgunes N. Longitudinal evaluation of prostaglandin E2 (PGE2) and periodontal status in HIV+ patients. Arch Oral Biol 2007: 52: 1102-1108.
7. Alpagot T, Suzara V, Bhattacharyya M. The associations between gingival crevice fluid matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and periodontitis in human immunodeficiency virus-positive patients. J Periodontal Res 2006: 41: 491-497.
8. Alves M, Mulligan R, Passaro D, Gawell S, Navazesh M, Phelan J, Greenspan D, Greenspan JS. Longitudinal evaluation of loss of attachment in HIV-infected women compared to HIV-uninfected women. J Periodontol 2006: 77: 773-779.
9. Anil S, Challacombe SJ. Oral lesions of HIV and AIDS in Asia: an overview. Oral Dis 1997: 3(Suppl 1): S36-40.
10. Arendorf TM, Bredekamp B, Cloete CA, Sauer G. Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med 1998: 27: 176-179.
11. Arendorf TM, Bredekamp B, Cloete C, Wood R, O'Keefe E. Intergroup comparisons of oral lesions in HIV-positive South Africans. Oral Dis 1997: 3(Suppl 1): S54-57.
12. Baqui AA, Meiller TF, Jabra-Rizk MA, Zhang M, Kelley JI, Falkler WA Jr. Enhanced interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in gingival crevicular fluid from periodontal pockets of patients infected with human immunodeficiency virus 1. Oral Microbiol Immunol 2000: 15: 67-73.
13. Barr C, Lopez MR, Rua-Dobles A. Periodontal changes by HIV serostatus in a cohort of homosexual and bisexual men. J Clin Periodontol 1992: 19: 794-801.
14. Bensadoun RJ, Daoud J, El Gueddari B, Bastit L, Gourmet R, Rosikon A, Allavena C, Ceruse P, Calais G, Attali P. Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer. Cancer 2008: 112: 204-211.
15. Bonito AJ, Patton LL, Shugars DA, Lohr KN, Nelson JP, Bader JP, Jackman AW. Management of dental patients who are HIV positive. Evid Rep Technol Assess (Summ) 2001: 37: 1-6.
16. Borg-von Zepelin M, Meyer I, Thomssen R, Wurzner R, Sanglard D, Telenti A, Monod M. HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol 1999: 113: 747-751.
17. Brito A, Escalona LA, Correnti M, Perrone M, Bravo IM, Tovar V. Periodontal conditions and distribution of Prevotella intermedia, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans in HIV-infected patients undergoing anti-retroviral therapy and in an HIV-seronegative group of the Venezuelan population. Acta Odontol Latinoam 2008: 21: 89-96.
18. Casper C, Wald A. The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma. Curr Top Microbiol Immunol 2007: 312: 289-307.
19. Cavasin Filho JC, Giovani EM. Xerostomy, dental caries and periodontal disease in HIV+ patients. Braz J Infect Dis 2009: 13: 13-17.
20. CDC (Centers for Disease Control). Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men: New York City and California. MMWR Morb Mortal Wkly Rep 1981: 30: 305-308.
21. Chattin BR, Ishihara K, Okuda K, Hirai Y, Ishikawa T. Specific microbial colonizations in the periodontal sites of HIV-infected subjects. Microbiol Immunol 1999: 43: 847-852.
22. Chidzonga MM. HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial surgical clinics. Oral Dis 2003: 9: 317-322.
23. Choromanska M, Waszkiel D. Periodontal status and treatment needs in HIV-infected patients. Adv Med Sci 2006: 51(Suppl 1): 110-113.
24. Cobb CM, Ferguson BL, Keselyak NT, Holt LA, MacNeill SR, Rapley JW. A TEM/SEM study of the microbial plaque overlying the necrotic gingival papillae of HIV-seropositive, necrotizing ulcerative periodontitis. J Periodontal Res 2003: 38: 147-155.
25. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011: 365: 493-505.
26. Contreras A, Mardirossian A, Slots J. Herpesviruses in HIV-periodontitis. J Clin Periodontol 2001: 28: 96-102.
27. Coogan M, Greenspan J, Challacombe S. Oral lesions in infection with human immunodeficiency virus. Bull World Health Organ 2005: 83: 1-16.
28. Cullough MJWA, Hodgson TA, Jorge JA. Susceptibility of oral yeast isolated from patients in Blantyre, Malawi to fluconazole and gentian violet [abstract 644]. In: Thirty-ninth Annual Meeting of the Infectious Diseases Society of America. San Francisco, CA: 2001.
29. Cutler CW, Jotwani R. Oral mucosal expression of HIV-1 receptors, co-receptors, and alpha-defensins: tableau of resistance or susceptibility to HIV infection? Adv Dent Res 2006: 19: 49-51.
30. Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L, Di Trolio R, De Placido S, Dezube BJ. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol 2007: 8: 167-176.
31. Dias EP, Israel MS, Silva Junior A, Maciel VA, Gagliardi JP, Oliveira RH. Prevalence of oral hairy leukoplakia in 120 pediatric patients infected with HIV-1. Braz Oral Res 2006: 20: 103-107.
32. Dios PD, Ocampo A, Miralles C, Limeres J, Tomas I. Changing prevalence of human immunodeficiency virus-associated oral lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000: 90: 403-404.
33. Dodd CL, Winkler JR, Heinic GS, Daniels TE, Yee K, Greenspan D. Cytomegalovirus infection presenting as acute periodontal infection in a patient infected with the human immunodeficiency virus. J Clin Periodontol 1993: 20: 282-285.
34. Dodson TB. HIV status and the risk of post-extraction complications. J Dent Res 1997: 76: 1644-1652.
35. Duggal MS, Abudiak H, Dunn C, Tong HJ, Munyombwe T. Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS. Eur Arch Paediatr Dent 2010: 11: 242-246.
36. ECC. EC-Clearinghouse on Oral Problems related to HIV infection and WHO collaborating center on Oral manifestations of the immunodeficiency virus Classification and diagnosis criteria for oral lesion in HIV infection. J Oral Pathol Med 1993: 22: 289-291.
37. Engeland CG, Jang P, Alves M, Marucha PT, Califano J. HIV infection and tooth loss. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008: 105: 321-326.
38. Falasca K, Vecchiet F, Ucciferri C, Vignale F, Conti P, Pizzigallo A, Piattelli A, Vecchiet J. Periodontitis and cytokine patterns in HIV positive patients. Eur J Med Res 2008: 13: 163-168.
39. Fauci AS. AIDS: let science inform policy. Science 2011: 333: 13.
40. Fauci A, Lane HC. Human Immunodeficiency Virus (HIV) Disease: AIDS and Related Disorders. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL. editors. Harrison's Principles of Internal Medicine, 14th edn. New York, NY: McGraw Hill, 1998: 1791-1856.
41. Fauci A, Lane HC. Human Immunodeficiency Virus Disease: AIDS and Related Disorders. In: Kasper DL, Braunwald E, Hauser SL, Longo DL, editor. Harrison's Principles of Internal Medicine, 16th edn. New York, NY: McGraw Hill, 2005: 1076-1139
42. Flint S, Tappuni A. Markers of immunodeficiency and Mechanisms of HAART Therapy on Oral Lesions. Adv Dent Res 2006: 19: 146-151.
43. Folkers GK, Fauci AS. Controlling and ultimately ending the HIV/AIDS pandemic: a feasible goal. JAMA 2010: 304: 350-351.
44. Giacaman RA, Asrani AC, Gebhard KH, Dietrich EA, Vacharaksa A, Ross KF, Herzberg MC. Porphyromonas gingivalis induces CCR5-dependent transfer of infectious HIV-1 from oral keratinocytes to permissive cells. Retrovirology 2008: 5: 29.
45. Glick M, Abel SN, Muzyka BC, DeLorenzo M. Dental complications after treating patients with AIDS. J Am Dent Assoc 1994: 125: 296-301.
46. Glick M, Cleveland DB, Salkin LM, Alfaro-Miranda M, Fielding AF. Intraoral cytomegalovirus lesion and HIV-associated periodontitis in a patient with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 1991: 72: 716-720.
47. Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994: 77: 344-349.
48. Gomez RS, da Costa JE, Loyola AM, de Araujo NS, de Araujo VC. Immunohistochemical study of linear gingival erythema from HIV-positive patients. J Periodontal Res 1995: 30: 355-359.
49. Gona P, Van Dyke RB, Williams PL, Dankner WM, Chernoff MC, Nachman SA, Seage GR III. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA 2006: 296: 292-300.
50. Goncalves Lde S, Ferreira SM, Silva A Jr, Villoria GE, Costinha LH, Souto R, Uzeda MD, Colombo AP. Association of T CD4 lymphocyte levels and subgingival microbiota of chronic periodontitis in HIV-infected Brazilians under HAART. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004: 97: 196-203.
51. Goncalves Lde S, Goncalves BM, de Andrade MA, Alves FR, Junior AS. Drug interactions during periodontal therapy in HIV-infected subjects. Mini Rev Med Chem 2010: 10: 766-772.
52. Gonzalez OA, Ebersole JL, Huang CB. Supernatants from oral epithelial cells and gingival fibroblasts modulate human immunodeficiency virus type 1 promoter activation induced by periodontopathogens in monocytes/macrophages. Mol Oral Microbiol 2010: 25: 136-149.
53. Gonzalez OA, Li M, Ebersole JL, Huang CB. HIV-1 reactivation induced by periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves TLR2 and TLR9 activation in monocytes/macrophages. Clin Vaccine Immunol 2010: 17: 1417-1427.Erratum in: Clin Vaccine Immunol 2010: 17: 1825.
54. Grande SR, Imbronito AV, Okuda OS, Lotufo RF, Magalhaes MH, Nunes FD. Herpes viruses in periodontal compromised sites: comparison between HIV-positive and -negative patients. J Clin Periodontol 2008: 35: 838-845.
55. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapia M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernandez T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallas EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010: 363: 2587-2599.
56. Grassi MWC, Winkler JR, Murray PA. Management of HIV-associated periodontal diseases. In: Robertson PB, Greenspan JS, editors. Perspectives on Oral Manifestations of AIDS, San Diego, Calif. Littleton, MA: PSG Publishing Co Inc, 1988: 119-130.
57. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003: 74: 391-401.
58. Grbic JT, Lamster IB, Mitchell-Lewis D. Inflammatory and immune mediators in crevicular fluid from HIV-infected injecting drug users. J Periodontol 1997: 68: 249-255.
59. Grbic JT, Mitchell-Lewis DA, Fine JB, Phelan JA, Bucklan RS, Zambon JJ, Lamster IB. The relationship of candidiasis to linear gingival erythema in HIV-infected homosexual men and parenteral drug users. J Periodontol 1995: 66: 30-37.
60. Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001: 357: 1411-1412.
61. Greenspan D, Gange SJ, Phelan JA, Navazesh M, Alves ME, MacPhail LA, Mulligan R, Greenspan JS. Incidence of oral lesions in HIV-1-infected women: reduction with HAART. J Dent Res 2004: 83: 145-150.
62. Greenspan JS, Greenspan D. The epidemiology of the oral lesions of HIV infection in the developed world. Oral Dis 2002: 8(Suppl 2): 34-39.
63. Greenwood I, Zakrzewska JM, Robinson PG. Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7years. Oral Dis 2002: 8: 90-94.
64. Hamza OJ, Matee MI, Simon EN, Kikwilu E, Moshi MJ, Mugusi F, Mikx FH, Verweij PE, van der Ven AJ. Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health 2006: 6: 12.
65. Hernandez Vallejo G, Garcia MD, Lopez A, Mendieta C, Moskow BS. Unusual periodontal findings in an AIDS patient with Burkitt's lymphoma. A case report. J Periodontol 1989: 60: 723-727.
66. Hodgson TA. HIV-associated oral lesions: prevalence in Zambia. Oral Dis 1997: 3(Suppl 1): S46-50.
67. Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res 2006: 19: 57-62.
68. Hofer D, Hammerle CH, Grassi M, Lang NP. Long-term results of supportive periodontal therapy (SPT) in HIV-seropositive and HIV-seronegative patients. J Clin Periodontol 2002: 29: 630-637.
69. Holmstrup P. Non-plaque-induced gingival lesions. Ann Periodontol 1999: 4: 20-31.
70. Holmstrup P, Westergaard J. Periodontal diseases in HIV-infected patients. J Clin Periodontol 1994: 21: 270-280.
71. Howell RB, Jandinski JJ, Palumbo P, Shey Z, Houpt MI. Oral soft tissue manifestations and CD4 lymphocyte counts in HIV-infected children. Pediatr Dent 1996: 18: 117-120.
72. Huang CB, Alimova YV, Ebersole JL. HIV-1 reactivation in HIV-latently infected dendritic cells by oral microorganisms and LPS. Cell Immunol 2011: 268: 105-111.
73. Huang CB, Alimova YV, Strange S, Ebersole JL. Polybacterial challenge enhances HIV reactivation in latently infected macrophages and dendritic cells. Immunology 2011: 132: 401-409.
74. Huang CB, Emerson KA, Gonzalez OA, Ebersole JL. Oral bacteria induce a differential activation of human immunodeficiency virus-1 promoter in T cells, macrophages and dendritic cells. Oral Microbiol Immunol 2009: 24: 401-407.
75. Imai K, Ochiai K, Okamoto T. Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J Immunol 2009: 182: 3688-3695.
76. Johansson I, Saellstrom AK, Rajan BP, Parameswaran A. Salivary flow and dental caries in Indian children suffering from chronic malnutrition. Caries Res 1992: 26: 38-43.
77. Jonsson N, Zimmerman M, Chidzonga MM, Jonsson K. Oral manifestations in 100 Zimbabwean HIV/AIDS patients referred to a specialist centre. Cent Afr J Med 1998: 44: 31-34.
78. Jordan RA, Gangler P, Johren HP. Clinical treatment outcomes of periodontal therapy in HIV-seropositive patients undergoing highly active antiretroviral therapy. Eur J Med Res 2006: 11: 232-235.
79. Jotwani R, Muthukuru M, Cutler CW. Increase in HIV receptors/co-receptors/alpha-defensins in inflamed human gingiva. J Dent Res 2004: 83: 371-377.
80. Khongkunthian P, Grote M, Isaratanan W, Piyaworawong S, Reichart PA. Oral manifestations in 45 HIV-positive children from Northern Thailand. J Oral Pathol Med 2001: 30: 549-552.
81. King MD, Reznik DA, O'Daniels CM, Larsen NM, Osterholt D, Blumberg HM. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis 2002: 34: 641-648.
82. Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES, Shah KV, Gillison ML. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004: 189: 686-698.
83. Kroidl A, Schaeben A, Oette M, Wettstein M, Herfordt A, Haussinger D. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy. Eur J Med Res 2005: 10: 448-453.
84. Lamster IGJ, Grbic J, Fine J, Bucklan R, Mitchall-Lewis D, Phelan J, Zambon J. A critical review of periodontal diseases as a manifestation of HIV infection. In: Greenspan JS, Greeenspan D, editors. Oral Manifestations of HIV Infection. Chicago, IL: Quintessence Publishing Company, 1995: 247-256.
85. Lamster IB, Grbic JT, Bucklan RS, Mitchell-Lewis D, Reynolds HS, Zambon JJ. Epidemiology and diagnosis of HIV-associated periodontal diseases. Oral Dis 1997: 3(Suppl 1): S141-148.
86. Lamster IB, Grbic JT, Mitchell-Lewis DA, Begg MD, Mitchell A. New concepts regarding the pathogenesis of periodontal disease in HIV infection. Ann Periodontol 1998: 3: 62-75.
87. Lemos SS, Oliveira FA, Vencio EF. Periodontal disease and oral hygiene benefits in HIV seropositive and AIDS patients. Med Oral Patol Oral Cir Bucal 2010: 15: e417-421.
88. Lindan CP, Allen S, Serufilira A, Lifson AR, Van de Perre P, Chen-Rundle A, Batungwanayo J, Nsengumuremyi F, Bogaerts J, Hulley S. Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med 1992: 116: 320-328.
89. Lucartorto FM, Franker CK, Maza J. Postscaling bacteremia in HIV-associated gingivitis and periodontitis. Oral Surg Oral Med Oral Pathol 1992: 73: 550-554.
90. Lucht E, Heimdahl A, Nord CE. Periodontal disease in HIV-infected patients in relation to lymphocyte subsets and specific micro-organisms. J Clin Periodontol 1991: 18: 252-256.
91. Madinier I, Monteil RA. Human papillomaviruses in oral epithelial lesions. Comparative study between histopathology and immunohistochemistry in routine diagnosis. J Biol Buccale 1987: 15: 105-110.
92. Magalhaes MG, Bueno DF, Serra E, Goncalves R. Oral manifestations of HIV positive children. J Clin Pediatr Dent 2001: 25: 103-106.
93. Mardirossian A, Contreras A, Navazesh M, Nowzari H, Slots J. Herpesviruses 6, 7 and 8 in HIV- and non-HIV-associated periodontitis. J Periodontal Res 2000: 35: 278-284.
94. Mataftsi M, Skoura L, Sakellari D. HIV infection and periodontal diseases: an overview of the post-HAART era. Oral Dis 2011: 17: 13-25.
95. McArthur CP, Africa CW, Castellani WJ, Luangjamekorn NJ, McLaughlin M, Subtil-DeOliveira A, Cobb C, Howard P, Gustafson S, Palmer D, Miranda RN. Salivary gland disease in HIV/AIDS and primary Sjogren's syndrome: analysis of collagen I distribution and histopathology in American and African patients. J Oral Pathol Med 2003: 32: 544-551.
96. McKaig RG, Thomas JC, Patton LL, Strauss RP, Slade GD, Beck JD. Prevalence of HIV-associated periodontitis and chronic periodontitis in a southeastern US study group. J Public Health Dent 1998: 58: 294-300.
97. McNeil D. New cases of AIDS hit plateau. New York Times November 21, 2011.
98. Mealey BL. Periodontal implications: medically compromised patients. Ann Periodontol 1996: 1: 256-321.
99. Mellanen L, Ingman T, Lahdevirta J, Lauhio A, Ainamo A, Konttinen YT, Sukura A, Salo T, Sorsa T. Matrix metalloproteinases-1, -3 and -8 and myeloperoxidase in saliva of patients with human immunodeficiency virus infection. Oral Dis 1996: 2: 263-271.
100. Mellanen L, Salo T, Ingman T, Konttinen YT, Lahdevirta J, Sorsa T. 72-kDa and 92-kDa gelatinases in saliva of patients with human immunodeficiency virus infection. Acta Odontol Scand 1998: 56: 135-142.
101. Miziara ID, Weber R. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients. Oral Dis 2006: 12: 402-407.
102. Moore LV, Moore WE, Riley C, Brooks CN, Burmeister JA, Smibert RM. Periodontal microflora of HIV positive subjects with gingivitis or adult periodontitis. J Periodontol 1993: 64: 48-56.
103. Moskow BS, Hernandez G. Aggressive periodontal destruction and herpes zoster in a suspected AIDS patient. J Parodontol 1991: 10: 359-369.
104. Murray PA. Periodontal diseases in patients infected by human immunodeficiency virus. Periodontol 2000 1994: 6: 50-67.
105. Murray PA, Grassi M, Winkler JR. The microbiology of HIV-associated periodontal lesions. J Clin Periodontol 1989: 16: 636-642.
106. Murray PA, Winkler JR, Peros WJ, French CK, Lippke JA. DNA probe detection of periodontal pathogens in HIV-associated periodontal lesions. Oral Microbiol Immunol 1991: 6: 34-40.
107. Myint M, Odden K, Schreurs O, Halstensen TS, Schenck K. The gingival plasma cell infiltrate in HIV-positive patients with periodontitis is disorganized. J Clin Periodontol 1999: 26: 358-365.
108. Myint MM, Steinsvoll S, Odden K, Dobloug J, Schenck K. Salivary IgA responses to bacteria in dental plaque as related to periodontal and HIV infection status. Eur J Oral Sci 1997: 105: 562-570.
109. Myint M, Steinsvoll S, Yuan ZN, Johne B, Helgeland K, Schenck K. Highly increased numbers of leukocytes in inflamed gingiva from patients with HIV infection. AIDS 2002: 16: 235-243.
110. Myint M, Yuan ZN, Schenck K. Reduced numbers of Langerhans cells and increased HLA-DR expression in keratinocytes in the oral gingival epithelium of HIV-infected patients with periodontitis. J Clin Periodontol 2000: 27: 513-519.
111. Navazesh M, Mulligan R, Barron Y, Redford M, Greenspan D, Alves M, Phelan J. A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003: 95: 693-698.
112. Navazesh MMR, Pogoda J, Greenspan D, Alves M, Phelan J, Greenspan J, Slots J. The effect of HAART on salivary microbiota in the Women's Interagency HIV Study (WIHS). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005: 100: 701-708.
113. Ndiaye CF, Critchlow CW, Leggott PJ, Kiviat NB, Ndoye I, Robertson PB, Georgas KN. Periodontal status of HIV-1 and HIV-2 seropositive and HIV seronegative female commercial sex workers in Senegal. J Periodontol 1997: 68: 827-831.
114. Nicolatou-Galitis O, Velegraki A, Paikos S, Economopoulou P, Stefaniotis T, Papanikolaou IS, Kordossis T. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study. Oral Dis 2004: 10: 145-150.
115. Nittayananta W, Chanowanna N, Jealae S, Nauntofte B, Stoltze K. Hyposalivation, xerostomia and oral health status of HIV-infected subjects in Thailand before HAART era. J Oral Pathol Med 2010: 39: 28-34.
116. Nittayananta W, Chanowanna N, Sripatanakul S, Winn T. Risk factors associated with oral lesions in HIV-infected heterosexual people and intravenous drug users in Thailand. J Oral Pathol Med 2001: 30: 224-230.
117. Nittayananta W, Chungpanich S. Oral lesions in a group of Thai people with AIDS. Oral Dis 1997: 3(Suppl 1): S41-45.
118. Nittayananta W, Talungchit S, Jaruratanasirikul S, Silpapojakul K, Chayakul P, Nilmanat A, Pruphetkaew N. Effects of long-term use of HAART on oral health status of HIV-infected subjects. J Oral Pathol Med 2010: 39: 397-406.
119. Nyst MJ, Perriens JH, Kimputu L, Lumbila M, Nelson AM, Piot P. Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients. Ann Soc Belg Med Trop 1992: 72: 45-52.
120. Odden K, Schenck K, Hurlen B. High numbers of T cells in gingiva from patients with human immunodeficiency virus (HIV) infection. J Oral Pathol Med 1995: 24: 413-419.
121. Odden K, Schenck K, Koppang H, Hurlen B. Candidal infection of the gingiva in HIV-infected persons. J Oral Pathol Med 1994: 23: 178-183.
122. Olaniyi TO, Sunday P. Oral manifestations of HIV infection in 36 Nigerian children. J Clin Pediatr Dent 2005: 30: 89-92.
123. Palmer GD, Morgan PR, Challacombe SJ. T-cell lymphoma associated with periodontal disease and HIV infection. A case report. J Clin Periodontol 1993: 20: 378-380.
124. Paster BJ, Russell MK, Alpagot T, Lee AM, Boches SK, Galvin JL, Dewhirst FE. Bacterial diversity in necrotizing ulcerative periodontitis in HIV-positive subjects. Ann Periodontol 2002: 7: 8-16.
125. Patel M, Coogan M, Galpin JS. Periodontal pathogens in subgingival plaque of HIV-positive subjects with chronic periodontitis. Oral Microbiol Immunol 2003: 18: 199-201.
126. Patton LL, McKaig R. Rapid progression of bone loss in HIV-associated necrotizing ulcerative stomatitis. J Periodontol 1998: 69: 710-716.
127. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000: 89: 299-304.
128. Patton LL, Phelan JA, Ramos-Gomez FJ, Nittayananta W, Shiboski CH, Mbuguye TL. Prevalence and classification of HIV-associated oral lesions. Oral Dis 2002: 8(Suppl 2): 98-109.
129. Patton LL, Shugars DA, Bonito AJ. A systematic review of complication risks for HIV-positive patients undergoing invasive dental procedures. J Am Dent Assoc 2002: 133: 195-203.
130. Petersen PE. Policy for prevention of oral manifestations in HIV/AIDS: the approach of the WHO Global Oral Health Program. Adv Dent Res 2006: 19: 17-20.
131. Phelan J. Dental lesions: diagnosis and treatment. Oral Dis 1997: 3: S235-237.
132. Phiri R, Feller L, Blignaut E. The severity, extent and recurrence of necrotizing periodontal disease in relation to HIV status and CD4+ T cell count. J Int Acad Periodontol 2010: 12: 98-103.
133. Pistorius A, Willershausen B. Cases of HIV-associated characteristic periodontal diseases. Eur J Med Res 1999: 4: 121-125.
134. Portela MB, Souza IP, Abreu CM, Bertolini M, Holandino C, Alviano CS, Santos AL, Soares RM. Effect of serine-type protease of Candida spp. isolated from linear gingival erythema of HIV-positive children: critical factors in the colonization. J Oral Pathol Med 2010: 39: 753-760.
135. Porter SR, Scully C, Luker J. Complications of dental surgery in persons with HIV disease. Oral Surg Oral Med Oral Pathol 1993: 75: 165-167.
136. Race EM, Adelson-Mitty J, Kriegel GR, Barlam TF, Reimann KA, Letvin NL, Japour AJ. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998: 351: 252-255.
137. Ramirez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, Gonzalez-Ramirez I, Ponce-de-Leon S. The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1, 000 consecutive patients: A 12-year study in a referral center in Mexico. Medicine (Baltimore) 2003: 82: 39-50.
138. Rams TE, Andriolo M Jr, Feik D, Abel SN, McGivern TM, Slots J. Microbiological study of HIV-related periodontitis. J Periodontol 1991: 62: 74-81.
139. Ranganathan K, Geethalakshmi E, Krishna Mohan Rao U, Vidya KM, Kumarasamy N, Solomon S. Orofacial and systemic manifestations in 212 paediatric HIV patients from Chennai, South India. Int J Paediatr Dent 2010: 20: 276-282.
140. Ranganathan K, Hemalatha R. Oral lesions in HIV infection in developing countries: an overview. Adv Dent Res 2006: 19: 63-68.
141. Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswanathan R, Johnson NW. Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients. Oral Dis 2000: 6: 152-157.
142. Reddy J. Control of HIV/AIDS and AIDS-related conditions in Africa with special reference to periodontal diseases. J Int Acad Periodontol 2007: 9: 2-12.
143. Reichart PA, Khongkhunthian P, Bendick C. Oral manifestations in HIV-infected individuals from Thailand and Cambodia. Med Microbiol Immunol 2003: 192: 157-160.
144. Robinson P. Treatment of HIV-associated periodontal diseases. Oral Dis 1997: 3: S238-240.
145. Robinson PG, Cooper H, Hatt J. Healing after dental extractions in men with HIV infection. Oral Surg Oral Med Oral Pathol 1992: 74: 426-430.
146. Robinson PG, Sheiham A, Challacombe SJ, Wren MW, Zakrzewska JM. Gingival ulceration in HIV infection. A case series and case control study. J Clin Periodontol 1998: 25: 260-267.
147. Robinson PG, Sheiham A, Challacombe SJ, Zakrzewska JM. Periodontal health and HIV infection. Oral Dis 1997: 3(Suppl 1): S149-152.
148. Ryder MI. Periodontal management of HIV-infected patients. Periodontol 2000 2000: 23: 85-93.
149. Ryder MI. An update on HIV and periodontal disease. J Periodontol 2002: 73: 1071-1078.
150. Ryder MI, Winkler JR, Weinreb RN. Elevated phagocytosis, oxidative burst, and F-actin formation in PMNs from individuals with intraoral manifestations of HIV infection. J Acquir Immune Defic Syndr 1988: 1: 346-353.
151. Salama C, Finch D, Bottone EJ. Fusospirochetosis causing necrotic oral ulcers in patients with HIV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004: 98: 321-323.
152. Santo AE, Tagliaferro EP, Ambrosano GM, Meneghim MC, Pereira AC. Dental status of Portuguese HIV+ patients and related variables: a multivariate analysis. Oral Dis 2010: 16: 176-184.
153. Santos LC, Castro GF, de Souza IP, Oliveira RH. Oral manifestations related to immunosuppression degree in HIV-positive children. Braz Dent J 2001: 12: 135-138.
154. Sardi JC, Almeida AM, Mendes Giannini MJ. New antimicrobial therapies used against fungi present in subgingival sites-A brief review. Arch Oral Biol 2011: 56: 951-959.
155. Schiodt M, Bakilana PB, Hiza JF, Shao JF, Bygbjerg IB, Mbaga I, Vestergaard BF, Nielsen CM, Lauritzen E, Lerche B, Kuijlen K. Oral candidiasis and hairy leukoplakia correlate with HIV infection in Tanzania. Oral Surg Oral Med Oral Pathol 1990: 69: 591-596.
156. Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 2000: 29: 336-341.
157. van Sighem AI, Gras LA, Reiss P, Brinkman K, de Wolf F. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS 2010: 24: 1527-1535.
158. Silva-Boghossian C, Castro GF, Teles RP, De Souza IP, Colombo AP. Salivary microbiota of HIV-positive children and its correlation with HIV status, oral diseases, and total secretory IgA. Int J Paediatr Dent 2008: 18: 205-216.
159. Slots J, Contreras A. Herpesviruses: a unifying causative factor in periodontitis? Oral Microbiol Immunol 2000: 15: 277-280.
160. Smolak A. Contextual factors influencing HIV risk behaviour in Central Asia. Cult Health Sex 2010: 12: 515-527.
161. de Souza Goncalves L, Souto R, Colombo AP. Detection of Helicobacter pylori, Enterococcus faecalis, and Pseudomonas aeruginosa in the subgingival biofilm of HIV-infected subjects undergoing HAART with chronic periodontitis. Eur J Clin Microbiol Infect Dis 2009: 28: 1335-1342.
162. Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005: 352: 1317-1323.
163. Steinsvoll S, Myint M, Odden K, Berild D, Schenck K. Reduced serum IgG reactivities with bacteria from dental plaque in HIV-infected persons with periodontitis. J Clin Periodontol 1997: 24: 823-829.
164. Traboulsi RS, Mukherjee PK, Ghannoum MA. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients. Int J Antimicrob Agents 2008: 31: 272-276.
165. Tukutuku K, Muyembe-Tamfum L, Kayembe K, Odio W, Kandi K, Ntumba M. Oral manifestations of AIDS in a heterosexual population in a Zaire hospital. J Oral Pathol Med 1990: 19: 232-234.
166. Umadevi M, Adeyemi O, Patel M, Reichart PA, Robinson PG. Periodontal diseases and other bacterial infections. Adv Dent Res 2006: 19: 139-145.
167. UNAIDS/WHO. AIDS Epidemic Update. December 2004. Geneva, Switzerland: UNAIDS/WHO, 2004.
168. UNAIDS/WHO. UNAIDS Report on the Global AIDS Epidemic. Geneva, Switzerland: UNAIDS/WHO, 2010.
169. Van Roey J, Haxaire M, Kamya M, Lwanga I, Katabira E. Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. J Acquir Immune Defic Syndr 2004: 35: 144-150.
170. Vaseliu N, Carter AB, Kline NE, Kozinetz C, Cron SG, Matusa R, Kline MW. Longitudinal study of the prevalence and prognostic implications of oral manifestations in romanian children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J 2005: 24: 1067-1071.
171. Vastardis SA, Yukna RA, Fidel PL Jr, Leigh JE, Mercante DE. Periodontal disease in HIV-positive individuals: association of periodontal indices with stages of HIV disease. J Periodontol 2003: 74: 1336-1341.
172. Vernon LT, Babineau DC, Demko CA, Lederman MM, Wang X, Toossi Z, Weinberg A, Rodriguez B. A prospective cohort study of periodontal disease measures and cardiovascular disease markers in HIV-infected adults. AIDS Res Hum Retroviruses 2011: 27: 1157-1166.
173. Vernon LT, Demko CA, Whalen CC, Lederman MM, Toossi Z, Wu M, Han YW, Weinberg A. Characterizing traditionally defined periodontal disease in HIV+ adults. Community Dent Oral Epidemiol 2009: 37: 427-437.
174. Walker AS, Mulenga V, Sinyinza F, Lishimpi K, Nunn A, Chintu C, Gibb DM. Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial. J Acquir Immune Defic Syndr 2006: 42: 637-645.
175. Wandera MN, Engebretsen IM, Rwenyonyi CM, Tumwine J, Astrom AN. Periodontal status, tooth loss and self-reported periodontal problems effects on oral impacts on daily performances, OIDP, in pregnant women in Uganda: a cross-sectional study. Health Qual Life Outcomes 2009: 7: 89.
176. Wang Q, Liu H, Qiao N. Effects of traditional Chinese medicine on salivary glands in the patients with head and neck cancer during radiotherapy. Zhongguo Zhong Xi Yi Jie He Za Zhi 1998: 18: 662-664.
177. WHO. AIDS Epidemic Update: Eastern and Central Asia. Geneva: World Health Organization. 2006.
178. Williams CA, Winkler JR, Grassi M, Murray PA. HIV-associated periodontitis complicated by necrotizing stomatitis. Oral Surg Oral Med Oral Pathol 1990: 69: 351-355.
179. Winkler JR, Murray PA, Grassi M, Hammerle C. Diagnosis and management of HIV-associated periodontal lesions. J Am Dent Assoc 1989: 119(Suppl): 25S-34S.
180. Wood NH, Blignaut E, Lemmer J, Meyerov R, Feller L. Necrotizing periodontal diseases in a semirural district of South Africa. AIDS Res Treat 2011: 2011: 638584.
181. Wright SC, Maree JE, Sibanyoni M. Treatment of oral thrush in HIV/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet. Phytomedicine 2009: 16: 118-124.
182. Yengopal V, Bhayat A, Coogan M. Pediatric oral HIV research in the developing world. Adv Dent Res 2011: 23: 61-66.
183. Yeung S, Serb P. HIV infection and the dentist. 2. The diagnosis and management of gingivitis and periodontitis. Aust Dent J 1994: 39: 73-76.
184. Yeung SC, Stewart GJ, Cooper DA, Sindhusake D. Progression of periodontal disease in HIV seropositive patients. J Periodontol 1993: 64: 651-657.
185. Zakrzewska JM, Atkin PA. Oral mucosal lesions in a UK HIV/AIDS oral medicine clinic. a nine year, cross-sectional, prospective study. Oral Health Prev Dent 2003: 1: 73-79.
186. Zambon JJ. Rapid diagnosis of periodontal infections: findings in AIDS patients. Immunol Invest 1997: 26: 55-65.
187. Zambon JJ, Reynolds HS, Genco RJ. Studies of the subgingival microflora in patients with acquired immunodeficiency syndrome. J Periodontol 1990: 61: 699-704.